Clinical Trials Search Tool

A Research Study Investigating Semaglutide in People With Early Alzheimer’s Disease

Disease/Condition: Alzheimer’s disease

Location: Portland

Ages: 55-85

Enrollment Opens: 04-01-2022

Enrollment Closes: TBD

Description:

This trial is called the EVOKE trial, and is sponsored by Novo Nordisk A/S. For more information, please visit https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=39097

Study ID: NN6535-4730

To Enroll: Call 503-476-9788 or schedule your free over-the-phone memory screen here: https://www.centerforcognitivehealth.com/resources/free-memory-screens/

Posted by: Center for Cognitive Health | https://www.centerforcognitivehealth.com/clinicaltrials/